2022 Annual Meeting Meeting Banner

Scientific Sessions

Scientific Abstracts will be presented in three formats at the 23rd ASBrS Annual Meeting. Presentation instructions, award eligibility, and publication opportunities are outlined in Scientific Session Instructions (PDF).

  • Oral—Oral Presentations will be held during the Scientific Session on Friday, April 8 and Saturday, April 9, 2022. Each presentation is 6 minutes, followed by 2-3 minutes for questions.

  • Quickshot—Quickshot Presentations will be held on Friday, April 8, 2022. Each presentation is 3 minutes, followed by 2 minutes for questions.

  • Poster—The poster session and reception will be held on Friday, April 8, 2022.

Scientific Session Oral Presentations I

Friday, April 8, 2:30–3:45 PM

Moderators: Sarah Blair, MD, FACS; Elizabeth Shaughnessy, MD, PhD, FACS, FSSO
  1. Oncotype Dx scores and Nodal Status in Patients over 70 years old – Continue to Choose Wisely

    • Kyra Nicholson, MD
      NorthShore University HealthSystem & University of Chicago, Evanston, IL

  2. Margin Management and Adjuvant Therapy for Phyllodes Tumors: Practice Patterns of the American Society of Breast Surgeons Members

    • Emilia Diego, MD, FACS
      University of Pittsburgh, Pittsburgh, PA

  3. Text-based intervention increases mammography uptake among overdue patients at an urban safety-net hospital

    • Asha Nanda
      University of Missouri Kansas City School of Medicine, Kansas City, MO

  4. Economic impact of reducing re-excision rates after breast conserving surgery in a large, integrated health system

    • Jeffery Chakedis, MD, FACS
      The Permanente Medical Group, Lafayette, CA

  5. Breast-Specific Sensuality in Breast Cancer Survivors: Sexually Active or Not

    • Hannah Peifer
      Alpert Medical School of Brown University, Boston, MA

  6. Survival Outcomes in Patients Following Locoregional Treatment for DCIS: Analysis of the NCDB DCIS Special Study Cohort

    • Sabrina Wang
      Duke University School of Medicine, Durham, NC

Scientific Session Oral Presentations II

Saturday, April 9, 1:45–3:00 PM

Moderators: Lola Fayanju, MD, MA, MPHS, FACS; Mediget Teshome, MD, MPH, FACS
  1. Nodal Pathologic Complete Response Rates in Luminal Breast Cancer Vary by Genomic Risk and Age

    • Judy C. Boughey, MD, FACS
      Department of Surgery, Mayo Clinic, Rochester, MN

  2. Is nodal clipping beneficial for patients receiving neoadjuvant chemotherapy?

    • Giacomo Montagna, MD, MPH
      Memorial Sloan Kettering Cancer Center, New York, NY

  3. Intervention to hepatic and pulmonary METastases in breast cancer patients: Prospective, multi-institutional registry study-IMET; Protocol MF 14-02

    • Atilla Soran, MD, MPH, FNBC, FACS
      Magee-Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, PA

  4. A DCIS biosignature with a novel residual risk subtype identifies patients with varying risk and RT benefit among younger and high grade DCIS patients

    • Brian J. Czerniecki, MD, PhD, FACS
      H Lee Moffitt Cancer Center, Tampa, FL

  5. Impact of Loco-regional Treatment on Survival in Young Patients with Operable Breast Cancer

    • Javier I. C. Orozco, MD, MSc
      Saint John's Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA

  6. The Male WhySurg Study: Patient and Surgeon Experience

    • Anna Chichura, MD
      NorthShore University Health System & University of Chicago, Evanston, IL

Quickshot Session Presentations

Friday April 8, 5:30–6:15 PM

Moderators: Daniel Leff, FRCS, MS (Hons), PhD; Tracy-Ann Moo, MD, FACS
  1. Does breast-conserving surgery with radiotherapy have a better survival than mastectomy? A meta-analysis of more than 1,500,000 patients

    • Manish Karamchandani, MD
      Tufts School of Medicine, Boston, MA

  2. A prospective clinical trial of immediate breast reconstruction following pre-mastectomy radiotherapy for operable breast cancer

    • Puneet Singh, MD
      UT MD Anderson Cancer Center, Houston, TX

  3. The Effect of Lymphatic Microsurgical Preventing Healing Approach (LYMPHA) on the Development of Upper Extremity Lymphedema Following Axillary Lymph Node Dissection in Breast Cancer Patients

    • Omar Qutob, MD
      Henry Ford Health System, Detroit, MI

  4. Axillary node positivity among suspicious but FNA negative nodes

    • Thomas Robbins
      Mayo Clinic, Rochester, MN

  5. Accuracy of Mammography, Ultrasound, Contrast Enhanced Digital Mammography and MRI on the Evaluation of Residual in Breast Disease After Neoadjuvant Endocrine Therapy

    • Chi Zhang, MD
      Mayo Clinic Arizona, Scottsdale, AZ

  6. Young Women with Breast Cancer: Does Surgical Approach Impact Overall Survival?

    • Christine Pestana, MD
      Atrium Health, Levine Cancer Institute, Winston-Salem, NC

  7. “Practice of Antibiotic Prophylaxis in Patients Undergoing Mastectomy with or without Immediate Reconstruction: A Survey of ASBrS Members.”

    • Abida Sattar, MD
      The Aga Khan University, Pakistan

Poster Session Presentations

Friday April 8, 6:15–7:30 PM

Abstract presenters will be available to discuss their posters with meeting attendees during this session.


Email: abstracts@breastsurgeons.org
Phone: 410‑381‑9500 or 877‑992‑5470 (M—F 8:30 am–5:00 pm et)